Control of eyelid retraction associated with Graves' disease with botulinum A toxin.
Two patients had satisfactory control of eyelid retraction associated with thyroid orbitopathy with repeated treatment of the levator palpebrae superioris muscle with botulinum A toxin. The effects of the toxin lasted for 3 to 4 months.
Biglan
A W
AW
Department of Ophthalmology, University of Pittsburgh School of Medicine, Pa.
D001905:Botulinum Toxins / Q000627:therapeutic use*; D005141:Eyelid Diseases / Q000209:etiology / Q000628:therapy*; D005260:Female; D006111:Graves Disease / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009801:Oculomotor Muscles / Q000187:drug effects
D001905:Botulinum Toxins